Natera, Inc. (NTRA): A Bull Case Theory
We came across a bullish thesis on Natera, Inc. (NTRA) on Substack by FJ Research. In this article, we will summarize the bulls’ thesis on NTRA. Natera, Inc.
Natera Inc. (NTRA)
Market is closed
Sector: Services-Medical Laboratories
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Farallon Capital Thomas Steyer | 4,547,809 | $643,105,671 | +3% | 3.59% |
| 2. | Citadel Investment Group Ken Griffin | 2,122,958 | $300,207,490 | +49% | 0.06% |
| 3. | Maverick Capital Lee Ainslie | 1,634,769 | $231,172,684 | +20% | 4.09% |
| 4. | Castle Hook Partners Josh Donfeld And David Rogers | 1,568,615 | $221,817,847 | +29% | 2.3% |
| 5. | Kynam Capital Derrick Tang | 1,167,570 | $165,106,074 | -43% | 13.87% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $29.56 | 19,011 | 420,000 | 2022-05-12 | Filing | ||
| $28.81 | 159,783 | 400,989 | 2022-05-12 | Filing | ||
| $28.09 | 41,026 | 241,026 | 2022-05-12 | Filing | ||
| $33.49 | 40,695 | Director | 1,291,584 | 2022-03-16 | Filing | |
| $32.59 | 85,903 | Director | 1,250,889 | 2022-03-16 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $165.05 | 600 | 5,704 | 2025-06-10 | Filing | ||
| $164.33 | 3,400 | 6,304 | 2025-06-10 | Filing | ||
| $159.12 | 100 | 133,205 | 2025-06-02 | Filing | ||
| $158.37 | 465 | 133,305 | 2025-06-02 | Filing | ||
| $157.23 | 1,145 | 133,770 | 2025-06-02 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 12,393,827 | $1,752,611,075 | 0.03% | |
| 2. | 10,440,588 | $1,476,403,484 | 0.03% | |
| 3. | 7,361,963 | $1,041,055,333 | 0.08% | |
| 4. | 3,370,551 | $476,629,617 | 0.02% | |
| 5. | 3,059,688 | $432,670,480 | 0.08% |
News See All
Natera, Inc. (NASDAQ:NTRA) Q1 2025 Earnings Call Transcript
Operator: Welcome to Natera's 2025 First Quarter Financial Results Conference Call. At this time, all participants are in a listen only mode [Operator Instructions].
13 Best Aggressive Growth Stocks to Buy Now
US stocks delivered a positive performance on Wednesday, April 23, after President Trump pointed out that he does not intend to fire Federal Reserve Chair Jerome Powell.
15 Stocks with Buy Ratings that Hedge Funds Love
The U.S. stock market has been in chaos ever since President Trump announced his intent to increase tariffs on the U.S.'s trading partners.
12 Best Diagnostics Stocks to Invest In Right Now
According to a report by Mordor Intelligence, the clinical diagnostics market has a size of $88.79 billion as of 2025.
Here’s What Lifted Natera (NTRA) in Q4 and 2024
Parnassus Investments, an investment management company, released the “Parnassus Growth Equity Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here.
15 Best Biotech Stocks to Buy According to Billionaires
Although biotech stocks had a "challenging" year in 2024, JPMorgan believes that some of the industry's companies could see significant growth in the months to come.
Natera, Inc. (NASDAQ:NTRA) Q4 2024 Earnings Call Transcript
Operator: Welcome everyone to Natera's 2024 Fourth Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Joe DiMenna’s Stock Portfolio: Top 10 Stocks to Buy
Zweig-DiMenna Associates Inc. is a U.S.-based hedge fund with a legacy spanning four decades. Established in 1984 by Joseph A.
Natera (NTRA) Surged on Blowout Quarterly Results
Baron Funds, an investment management company, released its “Baron Health Care Fund” fourth quarter 2024 investor letter.
Billionaire Hedge Funds
